Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 24Gastrointestinal 16Genitourinary 13Other 8Head & Neck 7Thoracic 5Other hematologic neoplasm 5Lymphoid 5Plasma cell 4Gynecologic 4CNS 4Tumor-Agnostic 2Sarcoma 2Other solid neoplasm 2Endocrine 2Other neoplasm 1Myeloid 1Dermatologic 1

Conditions

Pituitary Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Motor Activity 1Limb-girdle muscular dystrophy, type 2C 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Resistance Training × Endocrine × Clear all
NCT00786019 2023-07-12

InsITE

University of Colorado, Denver

Phase NA Completed
47 enrolled 22 charts
Endocrine

Limb-girdle muscular dystrophy, type 2C, Diabetes Mellitus, Diabetes Mellitus, Type 2, Motor Activity, Multiple Endocrine Neoplasia Type 1

NCT04284605 2021-10-27

Effects Exercise Training in Patients With Pituitary Adenoma

Hacettepe University

Phase NA Completed
10 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡